INDV Indivior Pharmaceuticals, Inc.

NASDAQ
$35.38

Indivior Pharmaceuticals, Inc. (INDV) SEC Filings

Everything INDV has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

49 filings
Date Form Filing
SCHEDULE 13G
8-K Acquisition Disposition · Capital Raise · Other Event · Reg Fd
8-K Agreement Terminated · Material Agreement
4
4
10-Q
4
4
4
4
4
4
4
4
4
4
4
10-Q
4
4
4
4
4
4
4
4
10-K
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
10-Q
10-Q
10-Q
10-K

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.